Neurology Live, a clinical neurologists focused media portal has published GN Corporation’s presentation at the MDA on the Clinical trial results of Neu REFIX in Duchenne Muscular Dystrophy
GN Corporation will present the results of preclinical and clinical studies with neu REFIX (N-163), one of its
NICHI BRITE (AFO-202), one of the NICHI GLUCAN brand products for overseas markets, has undergone clinical tri
Commemoration of World Parkinson’s Day 2023 Read More »
GNC’s activities are introduced in the Japan Cabinet Office’s site ‘Invest Japan’
This is the research on the potential of beta-glucan for autism
A breakthrough achievement on miRNA140 is published in Medicine Innovates
Rejuvenating human cartilage cells in the lab, proven by miRNA140 enhancement Read More »
An interview was published in a feature story in Bloomburg
GN Corp track record published in Bloomberg Read More »
GN Corporation participates in the “Autism Sunday” to be held on February 13, 2022
Autism Sunday 2022: Commemoration and Panel discussion Read More »
The NCRM NICHE 2021 is held virtually on 17 Oct 2021
